Encompass Health Corporation (NYSE:EHC) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lowered its position in shares of Encompass Health Corporation (NYSE:EHC) by 67.0% in the first quarter, Holdings Channel reports. The institutional investor owned 366,554 shares of the company’s stock after selling 743,967 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Encompass Health were worth $37,125,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Colonial Trust Co SC bought a new stake in shares of Encompass Health in the 4th quarter valued at approximately $29,000. Transce3nd LLC bought a new position in Encompass Health during the fourth quarter worth about $40,000. Arlington Trust Co LLC lifted its holdings in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock valued at $68,000 after purchasing an additional 125 shares in the last quarter. Signaturefd LLC increased its position in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after purchasing an additional 125 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in shares of Encompass Health during the 4th quarter worth approximately $72,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

EHC has been the subject of several recent research reports. Stephens upgraded Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price target for the company in a research report on Thursday, June 5th. Wall Street Zen cut Encompass Health from a “strong-buy” rating to a “buy” rating in a report on Friday, June 6th. Barclays raised their price objective on Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a research report on Friday, April 25th. Royal Bank Of Canada raised their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research note on Monday, April 28th. Finally, Truist Financial reissued a “buy” rating and set a $135.00 price objective (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $131.50.

Insider Buying and Selling

In other news, CEO Mark J. Tarr sold 118,384 shares of the business’s stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the completion of the sale, the chief executive officer owned 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP John Patrick Darby sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the sale, the executive vice president directly owned 79,710 shares in the company, valued at $9,149,910.90. This trade represents a 11.15% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 132,663 shares of company stock valued at $16,034,082. 2.00% of the stock is owned by company insiders.

Encompass Health Price Performance

Encompass Health stock opened at $110.28 on Friday. The stock has a market capitalization of $11.12 billion, a price-to-earnings ratio of 22.78, a PEG ratio of 2.23 and a beta of 0.88. The stock’s 50 day moving average price is $119.18 and its two-hundred day moving average price is $106.70. Encompass Health Corporation has a 52-week low of $82.74 and a 52-week high of $123.13. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The business’s revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.12 earnings per share. On average, equities analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st were paid a dividend of $0.17 per share. The ex-dividend date was Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.62%. Encompass Health’s payout ratio is currently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.